Literature DB >> 12616850

COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.

Wayne A Ray1, Thomas M MacDonald, Daniel H Solomon, David J Graham, Jerry Avorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12616850     DOI： 10.1002/pds.798

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  5 in total

Review 1.  Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences?

Authors:  Irmgard Tegeder; Gerd Geisslinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-04-04       Impact factor: 3.000

2.  Prescriptions for chronic high-dose cyclooxygenase-2 inhibitors are often inappropriate and potentially dangerous.

Authors:  Christianne L Roumie; Patrick G Arbogast; Edward F Mitchel; Marie R Griffin
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

Review 3.  Inflammation and shoulder pain--a perspective on rotator cuff disease, adhesive capsulitis, and osteoarthritis: conservative treatment.

Authors:  Bernardino Saccomanni
Journal:  Clin Rheumatol       Date:  2009-02-18       Impact factor: 2.980

4.  The role of chemoprevention by selective cyclooxygenase-2 inhibitors in colorectal cancer patients - a population-based study.

Authors:  Yi-Hsin Yang; Yea-Huei Kao Yang; Ching-Lan Cheng; Pei-Shan Ho; Ying-Chin Ko
Journal:  BMC Cancer       Date:  2012-12-06       Impact factor: 4.430

5.  Challenges facing age-management/longevity medicine.

Authors:  Richard F Walker
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.